Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.

Saran AR, Dave S, Zarrinpar A.

Gastroenterology. 2020 Feb 12. pii: S0016-5085(20)30221-3. doi: 10.1053/j.gastro.2020.01.050. [Epub ahead of print]

PMID:
32061597
2.

Human Skin, Oral, and Gut Microbiomes Predict Chronological Age.

Huang S, Haiminen N, Carrieri AP, Hu R, Jiang L, Parida L, Russell B, Allaband C, Zarrinpar A, Vázquez-Baeza Y, Belda-Ferre P, Zhou H, Kim HC, Swafford AD, Knight R, Xu ZZ.

mSystems. 2020 Feb 11;5(1). pii: e00630-19. doi: 10.1128/mSystems.00630-19.

3.

Enabling Technologies for Personalized and Precision Medicine.

Ho D, Quake SR, McCabe ERB, Chng WJ, Chow EK, Ding X, Gelb BD, Ginsburg GS, Hassenstab J, Ho CM, Mobley WC, Nolan GP, Rosen ST, Tan P, Yen Y, Zarrinpar A.

Trends Biotechnol. 2020 Jan 21. pii: S0167-7799(19)30316-6. doi: 10.1016/j.tibtech.2019.12.021. [Epub ahead of print] Review.

PMID:
31980301
4.

Liver-on-a-Chip Models of Fatty Liver Disease.

Hassan S, Sebastian S, Maharjan S, Lesha A, Carpenter AM, Liu X, Xie X, Livermore C, Zhang YS, Zarrinpar A.

Hepatology. 2020 Feb;71(2):733-740. doi: 10.1002/hep.31106. Review. No abstract available.

PMID:
31909504
5.

What Can We Learn About Drug Safety and Other Effects in the Era of Electronic Health Records and Big Data That We Would Not Be Able to Learn From Classic Epidemiology?

Zarrinpar A, David Cheng TY, Huo Z.

J Surg Res. 2020 Feb;246:599-604. doi: 10.1016/j.jss.2019.09.053. Epub 2019 Oct 22. Review.

PMID:
31653413
6.

Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.

Lunsford KE, Agopian VG, Yi SG, Nguyen DTM, Graviss EA, Harlander-Locke MP, Saharia A, Kaldas FM, Mobley CM, Zarrinpar A, Hobeika M, Veale JL, Podder H, Farmer DG, Knight RJ, Danovitch GM, Gritsch HA, Li XC, Ghobrial RM, Busuttil RW, Gaber AO.

Transplantation. 2019 Oct 23. doi: 10.1097/TP.0000000000003040. [Epub ahead of print]

PMID:
31651787
7.

Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial.

Thompson CC, Abu Dayyeh BK, Kushnir V, Kushner RF, Jirapinyo P, Schorr AB, Aronne LJ, Amaro A, Jaffe DL, Schulman AR, Early D, Stein AC, Sharaiha R, Edmundowicz SA, Bohning JM, Jensen MD, Shukla AP, Apovian C, Kim DW, Tran D, Zarrinpar A, Ryan MB, Young M, Lowe A, Haas M, Goldsmith H, McCrea J, Sullivan S.

Surg Obes Relat Dis. 2019 Aug;15(8):1348-1354. doi: 10.1016/j.soard.2019.04.026. Epub 2019 May 2.

PMID:
31302000
8.

Effect of Obesogenic Medications on Weight-Loss Outcomes in a Behavioral Weight-Management Program.

Desalermos A, Russell B, Leggett C, Parnell A, Ober K, Hagerich K, Gerlan C, Ganji G, Lee E, Proudfoot JA, Grunvald E, Gupta S, Ho SB, Zarrinpar A.

Obesity (Silver Spring). 2019 May;27(5):716-723. doi: 10.1002/oby.22444.

PMID:
31012292
9.

Factors predicting kidney delayed graft function among recipients of simultaneous liver-kidney transplantation: A single-center experience.

Korayem IM, Agopian VG, Lunsford KE, Gritsch HA, Veale JL, Lipshutz GS, Yersiz H, Serrone CL, Kaldas FM, Farmer DG, Bunnapradist S, Danovitch GM, Busuttil RW, Zarrinpar A.

Clin Transplant. 2019 Jun;33(6):e13569. doi: 10.1111/ctr.13569. Epub 2019 May 7.

10.

Quantitative Measure of Intestinal Permeability Using Blue Food Coloring.

Angarita SAK, Duarte S, Russell TA, Ruchala P, Elliott IA, Whitelegge JP, Zarrinpar A.

J Surg Res. 2019 Jan;233:20-25. doi: 10.1016/j.jss.2018.07.005. Epub 2018 Jul 27.

11.

A Targeted Swallow Screen for the Detection of Postoperative Dysphagia in Liver Transplant Patients.

Mukdad L, Toppen W, Nguyen S, Kim K, Mendelsohn AH, Zarrinpar A, Benharash P.

Prog Transplant. 2018 Dec 4:1526924818817035. doi: 10.1177/1526924818817035. [Epub ahead of print]

PMID:
30514164
12.

Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.

Zarrinpar A, Faltermeier CM, Agopian VG, Naini BV, Harlander-Locke MP, Kaldas FM, Farmer DG, Busuttil RW.

Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.

13.

The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: a retrospective cohort study.

Leggett CB, Desalermos A, Brown SD, Lee E, Proudfoot JA, Horgan S, Gupta S, Grunvald E, Ho SB, Zarrinpar A.

Int J Obes (Lond). 2019 Jun;43(6):1154-1163. doi: 10.1038/s41366-018-0207-x. Epub 2018 Sep 21.

14.

Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.

Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R.

Clin Gastroenterol Hepatol. 2019 Jan;17(2):218-230. doi: 10.1016/j.cgh.2018.09.017. Epub 2018 Sep 18. Review.

15.

Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.

Zarrinpar A, Chaix A, Xu ZZ, Chang MW, Marotz CA, Saghatelian A, Knight R, Panda S.

Nat Commun. 2018 Jul 20;9(1):2872. doi: 10.1038/s41467-018-05336-9.

16.

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.

Singh S, Facciorusso A, Singh AG, Vande Casteele N, Zarrinpar A, Prokop LJ, Grunvald EL, Curtis JR, Sandborn WJ.

PLoS One. 2018 May 17;13(5):e0195123. doi: 10.1371/journal.pone.0195123. eCollection 2018. Review. Erratum in: PLoS One. 2018 Aug 29;13(8):e0203499.

17.

High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis.

Kurnool S, Nguyen NH, Proudfoot J, Dulai PS, Boland BS, Vande Casteele N, Evans E, Grunvald EL, Zarrinpar A, Sandborn WJ, Singh S.

Aliment Pharmacol Ther. 2018 Jun;47(11):1472-1479. doi: 10.1111/apt.14665. Epub 2018 Apr 17.

18.

Hepatocyte transplantation: past efforts, current technology, and future expansion of therapeutic potential.

Anderson TN, Zarrinpar A.

J Surg Res. 2018 Jun;226:48-55. doi: 10.1016/j.jss.2018.01.031. Epub 2018 Feb 10. Review.

19.
20.

Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside.

Kageyama S, Nakamura K, Fujii T, Ke B, Sosa RA, Reed EF, Datta N, Zarrinpar A, Busuttil RW, Kupiec-Weglinski JW.

Hepatology. 2018 Jul;68(1):258-273. doi: 10.1002/hep.29787. Epub 2018 May 10.

21.

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma.

Tsirulnikov K, Duarte S, Ray A, Datta N, Zarrinpar A, Hwang L, Faull K, Pushkin A, Kurtz I.

J Cancer. 2018 Jan 1;9(1):1-12. doi: 10.7150/jca.21747. eCollection 2018.

22.

Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.

Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, Zarrinpar A, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.

JAMA Surg. 2018 May 1;153(5):436-444. doi: 10.1001/jamasurg.2017.5040. Erratum in: JAMA Surg. 2018 May 1;153(5):498.

23.

Heme oxygenase-1 regulates sirtuin-1-autophagy pathway in liver transplantation: From mouse to human.

Nakamura K, Kageyama S, Yue S, Huang J, Fujii T, Ke B, Sosa RA, Reed EF, Datta N, Zarrinpar A, Busuttil RW, Kupiec-Weglinski JW.

Am J Transplant. 2018 May;18(5):1110-1121. doi: 10.1111/ajt.14586. Epub 2017 Dec 18.

24.

Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury.

Nakamura K, Zhang M, Kageyama S, Ke B, Fujii T, Sosa RA, Reed EF, Datta N, Zarrinpar A, Busuttil RW, Araujo JA, Kupiec-Weglinski JW.

J Hepatol. 2017 Dec;67(6):1232-1242. doi: 10.1016/j.jhep.2017.08.010. Epub 2017 Aug 23.

25.

Sirtuin 1 attenuates inflammation and hepatocellular damage in liver transplant ischemia/Reperfusion: From mouse to human.

Nakamura K, Kageyama S, Ke B, Fujii T, Sosa RA, Reed EF, Datta N, Zarrinpar A, Busuttil RW, Kupiec-Weglinski JW.

Liver Transpl. 2017 Oct;23(10):1282-1293. doi: 10.1002/lt.24821.

26.

Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.

Court CM, Harlander-Locke MP, Markovic D, French SW, Naini BV, Lu DS, Raman SS, Kaldas FM, Zarrinpar A, Farmer DG, Finn RS, Sadeghi S, Tomlinson JS, Busuttil RW, Agopian VG.

Liver Transpl. 2017 Sep;23(9):1123-1132. doi: 10.1002/lt.24811.

27.

Making N-of-1 Medicine a Reality.

Ho D, Zarrinpar A.

SLAS Technol. 2017 Jun;22(3):231-232. doi: 10.1177/2472630317702449. No abstract available.

PMID:
28520523
28.

Metabolic Pathway Inhibition in Liver Cancer.

Zarrinpar A.

SLAS Technol. 2017 Jun;22(3):237-244. doi: 10.1177/2472630317698683. Epub 2017 Mar 17. Review.

PMID:
28314110
29.

Peritransplant pancreatitis: A marker of high mortality and graft failure in liver transplant patients.

Russell TA, Park S, Agopian VG, Zarrinpar A, Farmer DG, O'Neill S, Korayem I, Ebaid S, Gornbein J, Busuttil RW, Kaldas FM.

Liver Transpl. 2017 Jul;23(7):925-932. doi: 10.1002/lt.24760.

30.

Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.

Sosa RA, Zarrinpar A, Rossetti M, Lassman CR, Naini BV, Datta N, Rao P, Harre N, Zheng Y, Spreafico R, Hoffmann A, Busuttil RW, Gjertson DW, Zhai Y, Kupiec-Weglinski JW, Reed EF.

JCI Insight. 2016 Dec 8;1(20):e89679. doi: 10.1172/jci.insight.89679.

31.

The Therapeutic Potential of T Cell Metabolism.

Zarrinpar A, Bensinger SJ.

Am J Transplant. 2017 Jul;17(7):1705-1712. doi: 10.1111/ajt.14149. Epub 2017 Jan 19. Review.

32.

Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.

Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ.

Am J Gastroenterol. 2017 Mar;112(3):447-457. doi: 10.1038/ajg.2016.500. Epub 2016 Dec 6.

33.

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.

Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ.

Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):110-121. doi: 10.1038/nrgastro.2016.181. Epub 2016 Nov 30. Review.

34.

Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.

Palumbo T, Nakamura K, Lassman C, Kidani Y, Bensinger SJ, Busuttil R, Kupiec-Weglinski J, Zarrinpar A.

Transplantation. 2017 Feb;101(2):322-331. doi: 10.1097/TP.0000000000001552.

35.

The circadian coordination of cell biology.

Chaix A, Zarrinpar A, Panda S.

J Cell Biol. 2016 Oct 10;215(1):15-25. Review.

36.

Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.

Agopian VG, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Cheng EY, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.

JAMA Surg. 2017 Jan 1;152(1):55-64. doi: 10.1001/jamasurg.2016.3310.

37.

Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.

Marotz CA, Zarrinpar A.

Yale J Biol Med. 2016 Sep 30;89(3):383-388. eCollection 2016 Sep. Review.

38.

Diamonds, Digital Health, and Drug Development: Optimizing Combinatorial Nanomedicine.

Ho D, Zarrinpar A, Chow EK.

ACS Nano. 2016 Oct 25;10(10):9087-9092. doi: 10.1021/acsnano.6b06174. Epub 2016 Sep 28.

39.

Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement.

Lunsford KE, Bodzin AS, Markovic D, Zarrinpar A, Kaldas FM, Gritsch HA, Xia V, Farmer DG, Danovitch GM, Hiatt JR, Busuttil RW, Agopian VG.

Ann Surg. 2017 May;265(5):1016-1024. doi: 10.1097/SLA.0000000000001801.

PMID:
27232249
40.

Mind MELD or Ignore It at Your Peril.

Zarrinpar A.

JAMA Surg. 2016 Jul 20;151(7):e160839. doi: 10.1001/jamasurg.2016.0839. Epub 2016 Jul 20. No abstract available.

41.

Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform.

Zarrinpar A, Lee DK, Silva A, Datta N, Kee T, Eriksen C, Weigle K, Agopian V, Kaldas F, Farmer D, Wang SE, Busuttil R, Ho CM, Ho D.

Sci Transl Med. 2016 Apr 6;8(333):333ra49. doi: 10.1126/scitranslmed.aac5954.

42.

Intraoperative Laparoscopic Near-Infrared Fluorescence Cholangiography to Facilitate Anatomical Identification: When to Give Indocyanine Green and How Much.

Zarrinpar A, Dutson EP, Mobley C, Busuttil RW, Lewis CE, Tillou A, Cheaito A, Hines OJ, Agopian VG, Hiyama DT.

Surg Innov. 2016 Aug;23(4):360-5. doi: 10.1177/1553350616637671. Epub 2016 Mar 9.

43.

Targeting Dysbiosis for the Treatment of Liver Disease.

Anand G, Zarrinpar A, Loomba R.

Semin Liver Dis. 2016 Feb;36(1):37-47. doi: 10.1055/s-0035-1571276. Epub 2016 Feb 12. Review.

44.

Daily Eating Patterns and Their Impact on Health and Disease.

Zarrinpar A, Chaix A, Panda S.

Trends Endocrinol Metab. 2016 Feb;27(2):69-83. doi: 10.1016/j.tem.2015.11.007. Epub 2015 Dec 17. Review.

45.

Portable device for the analysis of liver function: a boon to liver surgery and critical care.

Mobley CM, Zarrinpar A.

Expert Rev Med Devices. 2016;13(1):1-4. doi: 10.1586/17434440.2016.1126178. Epub 2015 Dec 19.

46.

TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.

Uthaya Kumar DB, Chen CL, Liu JC, Feldman DE, Sher LS, French S, DiNorcia J, French SW, Naini BV, Junrungsee S, Agopian VG, Zarrinpar A, Machida K.

Gastroenterology. 2016 Mar;150(3):707-19. doi: 10.1053/j.gastro.2015.11.002. Epub 2015 Nov 12.

47.

Liver transplantation: Evading antigens-ABO-incompatible liver transplantation.

Zarrinpar A, Busuttil RW.

Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):676-8. doi: 10.1038/nrgastro.2015.193. Epub 2015 Nov 18. No abstract available.

PMID:
26577350
48.

Quantification of hepatic functional capacity: a call for standardization.

DuBray BJ, Zarrinpar A.

Expert Rev Gastroenterol Hepatol. 2016;10(1):9-11. doi: 10.1586/17474124.2016.1116938. Epub 2015 Dec 1. Erratum in: Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):603. John Dubray, B [corrected to DuBray, Bernard J].

PMID:
26561002
49.

The effects of time-restricted feeding on lipid metabolism and adiposity.

Chaix A, Zarrinpar A.

Adipocyte. 2015 Apr 20;4(4):319-24. doi: 10.1080/21623945.2015.1025184. eCollection 2015 Oct-Dec.

50.

A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.

Faltermeier C, Busuttil RW, Zarrinpar A.

Diseases. 2015 Sep 29;3(4):221-252. doi: 10.3390/diseases3040221. Review.

Supplemental Content

Loading ...
Support Center